Navigation Links
Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
Date:8/12/2011

rted confirmatory Phase 3 clinical trial for the treatment of acute GI GVHD. Soligenix is also conducting a National Cancer Institute (NCI)-supported Phase 1/2 clinical trial of SGX201 in the prevention of acute radiation enteritis. Additionally, Soligenix has a Lipid Polymer Micelle (LPM™) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, Soligenix is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. Soligenix’s lead biodefense product in development is a recombinant subunit vaccine called RiVax™, which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax™ has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax™ is currently the subject of a $9.4 million NIAID grant supporting development of new heat stable vaccines.  Soligenix is also developing SGX202 for the treatment of radiation injury and has recently released positive preliminary preclinical results in a canine gastrointestinal acute radiation syndrome model.

For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com.

This press release contains forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products base
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
2. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
3. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
4. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
5. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
6. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
7. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
8. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
9. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
10. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
11. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/9q4d5d/veterinary_ ) has ... Vaccines Market by Product, Diseases & Technology - Global ... The global animal vaccines market is poised to ... 2015, at a CAGR of 5.5% from 2015 to ... growing prevalence of animal diseases, increasing incidences of zoonotic ...
(Date:7/1/2015)... 1, 2015 The Coalition of State ... and regional professional rheumatology societies, today released the ... explored perceptions of biosimilars and the potential impact ... Biosimilars are medicines that are highly similar, ... notably different from generic medications in that it ...
(Date:7/1/2015)... , June 24, 2015 ... has announced the addition of the ... and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, ... 2015 New Frontiers in European ... Emerging Technologies, Competitive Landscape is a new ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2
(Date:7/2/2015)... ... 2015 , ... Denver-based SlimGenics Weight Control Centers, the leader ... 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz compiles the exclusive ... award identifies outstanding woman-owned businesses that demonstrate excellence and success in the industry ...
(Date:7/1/2015)... ... 2015 , ... With all final regulatory approvals in place ... N.Y., is now a member of national system Trinity Health, effective immediately. ... committed to delivering high-value care, said Richard J. Gilfillan, M.D., president and CEO, ...
(Date:7/1/2015)... ... 01, 2015 , ... For decades, researchers in the genetics field have theorized ... brain, never changing after development in the womb. Now, researchers from the Icahn School ... cells throughout life – a process which helps to switch genes on and off. ...
(Date:7/1/2015)... ... 01, 2015 , ... Ormco Corporation, a leading manufacturer and ... Smile for a Lifetime Foundation (S4L) fundraising event held at the 14th Annual ... S4L in its mission to provide free quality orthodontic care to individuals with ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and ... Community Trust. The grant will allow CCF to improve quality of care and save ... was formed to respond to many changes in New York’s Medicaid system. Experts agree ...
Breaking Medicine News(10 mins):Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... 02, 2009 The antiepileptic drug vigabatrin (VGB) has been ... special form of epilepsy in infants, called infantile spasm. However, ... has been shown to cause a permanent narrowing of visual ... exposed at school age or later. A new study published ...
... U.S. Ambassador to the United Republic of Tanzania, joins Malaria ... No More Policy Center in Washington, DC, the non-profit organization ... fight against malaria in Africa to his new role at ... advocacy work to engage policymakers in the race to save ...
... given awayFORT WORTH, Texas, Feb. 2 ... USA announces the launch of the second season ... 26, 2009, Marinela USA consumers can collect one ... specially marked boxes of Barritas Fresa, Barritas Pina, ...
... and only multi-module training program devoted exclusively to whiplash ... Stutzman, local Doctor of Chiropractic practicing in Paoli, PA ... specifically to whiplash and brain injury traumatology. The ... prestigious Spine Research Institute of San Diego . ...
... Danaher Corporation (NYSE: DHR ) announced ... L. Comas will be presenting at the Barclays Capital ... 9, 2009 at 1:35 p.m. EST. The audio will ... of the webcast will be available for one week ...
... Digirad Corporation (Nasdaq: DRAD ), a ... equipment leasing services that improve patient care while driving ... the assets related to three northern California service hub ... Fe, Calif.-based MD Office Solutions calls for the sale ...
Cached Medicine News:Health News:Controversial medication may decrease spasms for infants with epilepsy 2Health News:Recent U.S. Ambassador to Tanzania Mark Green Named Managing Director of Malaria No More Policy Center 2Health News:Marinela USA(R) Recharges ZumbAtomic for Second Season 2Health News:Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft 2Health News:Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft 3Health News:Digirad Corporation Sells Northern California Service Hubs 2
... Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No ... 100-1000 Inaccuracy (%) ... Imprecision(%) ... 10 Dimensions: ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... The new Finnpipette Focus from Thermo ... with uncompromising performance. Advanced features such ... .01ul fine volume adjustment on microvolumes help ... in single channel pipettes. The new interchangeable ...
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
Medicine Products: